In patients with multiple myeloma (MM), the bone marrow (BM) contains hematopoietic stem cells (HSCs) and non-hematopoietic cells. HSCs are able to give rise to all types of mature blood cells, while the non hematopoietic component includes mesenchymal stem cells (MSCs), fibroblasts, osteoblasts, osteoclasts, chondroclasts, endothelial cells, endothelial progenitor cells (EPCs), B and T lymphocytes, NK cells, erythrocytes, megakaryocytes, platelets, macrophages and mast cells. All of these cells form specialized "niches" in the BM microenvironment which are close to the vasculature ("vascular niche") or to the endosteum ("osteoblast niche"). The "vascular niche" is rich in blood vessels where endothelial cells and mural cells (pericytes and smooth muscle cells) create a microenvironment that affects the behavior of several stem and progenitor cells. The vessel wall serves as an independent niche for the recruitment of endothelial progenitor cells, MSCs and HSCs. The activation by angiogenic factors and inflammatory cytokines switch the "vascular niche" to promote MM tumor growth and spread. This review will focus on the mechanisms involved in the generation of signals released by endothelial cells in the "vascular niche" that promote tumor growth and spread in MM.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0049-3848(14)50017-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Mechanism of Bone-metastatic LUAD Cells Promoting Angiogenesis Through HGF/YAP Signaling Pathway].
Zhongguo Fei Ai Za Zhi
November 2024
College of Fisheries and Life Science, Shanghai Ocean University, Shanghai 201306, China.
Background: The early stages of tumor bone metastasis are closely associated with changes in the vascular niche of the bone microenvironment, and abnormal angiogenesis accelerates tumor metastasis and progression. However, the effects of lung adenocarcinoma (LUAD) cells reprogrammed by the bone microenvironment on the vascular niche within the bone microenvironment and the underlying mechanisms remain unclear. This study investigates the effects and mechanisms of LUAD cells reprogrammed by the bone microenvironment on endothelial cells and angiogenesis, providing insights into the influence of tumor cells on the vascular niche within the bone microenvironment.
View Article and Find Full Text PDFSelf-organization of the hematopoietic vascular niche and emergent innate immunity on a chip.
Cell Stem Cell
December 2024
Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Vivodyne Inc., Philadelphia, PA 19104, USA; Center for Innovation & Precision Dentistry, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; NSF Science and Technology Center for Engineering Mechanobiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:
Here, we present a bioengineering approach to emulate the human bone marrow in vitro. Our developmentally inspired method uses self-organization of human hematopoietic stem and progenitor cells and vascular endothelial cells cultured in a three-dimensional microphysiological system to create vascularized, perfusable tissue constructs that resemble the hematopoietic vascular niche of the human marrow. The microengineered niche is capable of multilineage hematopoiesis and can generate functionally mature human myeloid cells that can intravasate into perfused blood vessels, providing a means to model the mobilization of innate immune cells from the marrow.
View Article and Find Full Text PDFDual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment.
J Control Release
January 2025
Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, PR China. Electronic address:
Clinical treatment effects of breast cancer are heavily frustrated by the malignant crosstalk between tumor vasculature and breast cancer stem cells (BCSCs). This study introduces a two-phase therapeutic strategy targeting the interplay between tumor vasculature and BCSCs to overcome this challenge. Here, we an FLG/ZnPc nanoscissor, which combines mild photodynamic therapy (PDT) to generate reactive oxygen species (ROS) with vascular normalization therapy (VNT) to break the crosstalk between tumor vasculature and BCSCs.
View Article and Find Full Text PDFDevelopment of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment.
Blood Adv
January 2025
Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
Article Synopsis
- - Current hematology studies often use immunodeficient mouse models to test patient-derived stem cells, but these models struggle with effectively incorporating cells from patients with myelodysplastic syndromes (MDS).
- - Researchers created a new bone marrow organoid model from induced pluripotent stem cells (iPSCs) that accurately mimics the human bone marrow environment, improving the engraftment of MDS patient stem cells and reflecting their unique disease traits.
- - The organoid model demonstrated that stem cells from both normal donors and MDS patients could proliferate and maintain their characteristics in a supportive microenvironment, revealing distinct differentiation patterns that correlate with MDS's clinical features and opening up possibilities for personalized treatments.
Thrombopoietin mimetic therapy alleviates radiation-induced bone marrow vascular injury in a bone marrow transplant mouse model.
Front Oncol
October 2024
Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States.
Article Synopsis
- There is a need for therapies to address bone marrow dysfunction and organ toxicity following myeloablative injury during bone marrow transplantation (BMT), associated with damage to the vascular endothelium and other organs.* -
- The study aimed to assess the effects of the thrombopoietin mimetic drug JNJ-26366821 (TPOm) on the recovery of bone marrow vascularity in mice undergoing BMT after receiving radiation conditioning.* -
- Results indicated that while donor chimerism remained similar in TPOm and control-treated mice, the treatment enhanced bone marrow vasculature regeneration, showing dose-dependent improvements in microvascular density and other vascular metrics on day 14 post-BMT.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!